Skip to main content
Top
Literature
1.
go back to reference Charles NJ, Boyer DF (2017) Mixed-phenotype acute leukemia diagnostic criteria and pitfalls. Arch Pathol Lab Med 141:1462–1468CrossRefPubMed Charles NJ, Boyer DF (2017) Mixed-phenotype acute leukemia diagnostic criteria and pitfalls. Arch Pathol Lab Med 141:1462–1468CrossRefPubMed
2.
go back to reference Borowitz MJ, Bene MC, Harris NL et al (2008) Acute leukemias of ambiguous lineage. In: Swerdlo SH, Campo E, Harris NL (eds) WHO classification of tumors of hematopoietic and lymphoid tissues, 4th edn. IARC, Lyon, pp 150–155 Borowitz MJ, Bene MC, Harris NL et al (2008) Acute leukemias of ambiguous lineage. In: Swerdlo SH, Campo E, Harris NL (eds) WHO classification of tumors of hematopoietic and lymphoid tissues, 4th edn. IARC, Lyon, pp 150–155
3.
go back to reference Arber DA, Orazi A, Hasserjian R et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391–2405CrossRefPubMed Arber DA, Orazi A, Hasserjian R et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391–2405CrossRefPubMed
4.
5.
6.
go back to reference Peters JM, Ansari MQ (2011) Multiparameter flow cytometry in the diagnosis and management of acute leukemia. Arch Pathol Lab Med 135:44–54PubMed Peters JM, Ansari MQ (2011) Multiparameter flow cytometry in the diagnosis and management of acute leukemia. Arch Pathol Lab Med 135:44–54PubMed
7.
go back to reference Matutes E, Pickl WF, Van’t Veer M, Morilla R, Swansbury J, Strobl H et al (2011) Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification. Blood 117(11):3163–3171CrossRefPubMed Matutes E, Pickl WF, Van’t Veer M, Morilla R, Swansbury J, Strobl H et al (2011) Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification. Blood 117(11):3163–3171CrossRefPubMed
8.
go back to reference Choi W, Kim M, Lim J et al (2014) Four cases of chronic myelogenous leukemia in mixed phenotype blast phase at initial presentation mimicking mixed phenotype acute leukemia with t(9;22). Ann Lab Med 34:60–63CrossRefPubMed Choi W, Kim M, Lim J et al (2014) Four cases of chronic myelogenous leukemia in mixed phenotype blast phase at initial presentation mimicking mixed phenotype acute leukemia with t(9;22). Ann Lab Med 34:60–63CrossRefPubMed
9.
go back to reference Weir EG, Ali Ansari-Lari M, Batista DA et al (2007) Acute bilineal leukemia: a rare disease with poor outcome. Leukemia 21(11):2264–2270CrossRefPubMed Weir EG, Ali Ansari-Lari M, Batista DA et al (2007) Acute bilineal leukemia: a rare disease with poor outcome. Leukemia 21(11):2264–2270CrossRefPubMed
Metadata
Title
Mixed Phenotype Acute Leukemia, B/Myeloid with t(9;22): Diagnostic and Therapeutic Challenges
Authors
Namrata P. Awasthi
Poonam Singh
Narendra Agrawal
Publication date
01-01-2019
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 1/2019
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-018-1020-3

Other articles of this Issue 1/2019

Indian Journal of Hematology and Blood Transfusion 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine